Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
VirnetX held its 2026 Annual Meeting of Stockholders with shareholder votes on multiple proposals: election of Class I directors (Kendall Larsen and Gary W. Feiner), ratification of auditor Farber Hass Hurley LLP, advisory approval of named executive officer compensation, and approval of an amendment to the 2013 Equity Incentive Plan increasing the share reserve by 1,000,000 shares. Vote tallies for each proposal are disclosed with results for votes for, against, withheld, abstentions, and broker non-votes.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-16
Item 7.01
The filing discloses a press release highlighting five gene therapy programs targeting inherited retinal diseases. This is a material corporate development disclosure that does not fit neatly into the standard taxonomy categories—it is neither an earnings release, M&A activity, executive change, nor litigation. For a biotech company, disclosure of multiple gene therapy programs represents material pipeline information that would affect investor assessment of the company's prospects and competitive position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the results of Thryv Holdings' annual stockholder meeting held on June 11, 2026, including the election of two Class III directors (John Slater and Joseph A. Walsh), ratification of Grant Thornton LLP as independent auditor, and an advisory vote on named executive officer compensation. The detailed vote tallies for each proposal are the core content of the filing, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-16
Item 1.01
CarParts.com entered into a material $25 million asset-based revolving credit facility with First Business Specialty Finance on June 15, 2026, secured by substantially all company assets. This represents a significant financing transaction that materially affects the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 45%
filed 2026-06-16
Item 1.02
CarParts.com terminated its JPM Credit Facility, which typically signals a covenant breach, default, or financial distress event. The termination of the prior credit facility is material and suggests underlying financial stress, though the precise nature of the termination—whether voluntary, forced by breach, or consensual—cannot be definitively determined from the available disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Ingersoll Rand held its Annual Meeting of stockholders on June 11, 2026, with voting results on four proposals: election of ten directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the 2026 Omnibus Incentive Plan.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-16
This is a Capital Markets Day announcement disclosing Equinor's strategic plan through 2030, including production growth targets (150,000 boe/d increase to 2.3M boe/d), capital allocation guidance (USD 12B annual capex), and cash flow projections (30% CFFO growth, USD 40B+ free cash flow 2026-2030). While it includes capital distribution elements (share buyback doubling to USD 3B and dividend growth guidance), the primary substance is a comprehensive operational and strategic business plan with material forward-looking guidance on production, investment, and returns that would affect a reasonable investor's assessment of the company's direction and value creation potential.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
AutoZone announced a $1.5 billion share repurchase authorization, which is a material capital allocation decision affecting shareholder value and the company's financial position. While share repurchases are routine for mature companies, the magnitude and explicit Board authorization make this material to investors. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement), so "other_material" is the appropriate classification.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 98%
filed 2026-06-16
EX-99.1
The press release announces the successful closing of a $200 million private placement offering of 7.00% Senior Unsecured Notes due June 16, 2031. This is a material creation of a new direct financial obligation. The company explicitly states it will use proceeds to repay existing indebtedness and for general corporate purposes, and the offering was underwritten by multiple major financial institutions, confirming the materiality and significance of this debt issuance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-16
EX-99.1
This exhibit is a corporate presentation detailing Evogene's AI-driven drug and agrochemical discovery platform (ChemPass AI) and its pipeline collaborations. It discloses material operational and strategic developments including: (1) expanded collaboration with Google Cloud (initiated Feb. 2026) to integrate advanced AI agents into the discovery platform; (2) multiple pharma collaborations for oncology, metabolic disease, and immunology programs; (3) agrochemical pipeline progress including wheat blotch fungicide candidate (APTF-1) showing 18-month development timeline and strong in vivo efficacy. While the presentation emphasizes technology capabilities and market opportunity rather than discrete transactional events, the disclosed collaborations, pipeline advancement, and strategic partnerships constitute material operational developments affecting the company's business prospects and competitive positioning.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-16
EX-99.1
This press release announces a strategic partnership between Perion and Best Buy Canada to power a programmatic digital-out-of-home (DOOH) retail media network. The disclosure emphasizes market expansion into the high-growth retail media vertical, full-stack technology adoption (Ad Server, SSP, Header Bidding), and yield optimization benefits. While not a discrete M&A transaction, the partnership represents a material operational and strategic business development that expands Perion's footprint in retail media and demonstrates its ability to win enterprise-level mandates, supporting the company's "Perion One" strategy for sustainable, infrastructure-level revenue streams.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 98%
filed 2026-06-16
ICL Group completed a private offering of $800 million aggregate principal amount of senior unsecured notes due 2036, carrying a 6.036% coupon. The press release explicitly announces the "Completion of Senior Notes Offering" and details the terms, pricing, covenants, and credit ratings (BBB- by S&P and Fitch). This is a material creation of direct financial obligation under Item 2.03 of the 8-K taxonomy, and the $800 million principal amount is clearly material to a reasonable investor assessing the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-16
EX-99.1
YY Group announced completion of a US$20 million At-The-Market (ATM) equity offering program, raising gross proceeds with net proceeds of approximately US$19.1 million after sales commissions and expenses. ATM offerings are unregistered equity issuances that dilute existing shareholders. The company explicitly states the program is now "concluded" with "no further share sales" under this facility, confirming full utilization of the offering capacity. This is a material capital-raising event affecting shareholder equity.
View raw filing on EDGAR →
6-K
Financial Other
confidence 85%
filed 2026-06-16
EX-99.1
GigaMedia announces conversion of US$12.37 million in Aeolus convertible notes into 719.09 million preferred shares, increasing its ownership stake to 33.35% and triggering a change in accounting treatment from available-for-sale to equity method. This is a material financial transaction involving a significant investment position and accounting reclassification, but does not fit the specific categories of debt issuance, dilutive issuance, or M&A activity—it is a conversion and settlement of an existing investment instrument, best classified as a material financial event outside the named categories.
View raw filing on EDGAR →
6-K
Financial Other
confidence 85%
filed 2026-06-16
EX-99
Exhibit 99.1 discloses UMC's disposal of 1,174,694 shares of Novatek Microelectronics Corporation through conversion of zero-coupon exchangeable bonds due 2026, generating a gain of $386,963,843 NTD to retained earnings. This is a material asset disposition affecting the company's investment portfolio (42.27% of total assets, 57.85% of equity). Exhibit 99.2 is a routine monthly report of insider trading and pledge activity with no changes reported, which is administrative. The primary material event is the Novatek share disposal in 99.1.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 7.01
Fiserv announced commencement of a tender offer to repurchase approximately $1.5+ billion in outstanding senior notes (5.150% Notes due 2027 and 4.400% Notes due 2049), contingent on proceeds from a concurrent euro-denominated senior notes offering. This is a material debt refinancing/capital structure event that does not fit neatly into the standard M&A or covenant-breach categories—it is a voluntary debt tender offer with financing conditions, disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 1.01 or 2.04.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-16
Item 7.01
Olin Corporation and Huntsman Corporation announced a proposed all-stock merger of equals transaction pursuant to an Agreement and Plan of Merger entered into on June 15, 2026. The disclosure explicitly states this is a "proposed combination" and describes the merger agreement, making this a material M&A activity event. The joint press release and investor presentation attached as exhibits document the entry into this material acquisition/merger transaction.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-16
EX-99.1
NovaBridge announced FDA Fast Track Designation for givastomig in first-line HER2-negative metastatic gastric cancer, a significant regulatory milestone that accelerates development and review. While not a discrete M&A, financing, or executive event, this regulatory achievement materially advances the company's clinical development pathway and would affect a reasonable investor's assessment of the drug candidate's prospects. The designation enables more efficient progress toward a registrational Phase 3 trial and potential accelerated approval, representing a material operational and strategic advancement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-16
Item 2.02
The filing discloses financial results for the first fiscal quarter ended May 2, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement under Item 2.02, which is material to investors as it provides periodic financial performance data essential to assessing the registrant's operating results and financial condition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The disclosure centers on the appointment of Bradley J. Pickard as a Class II director to FreightCar America's Board, effective June 10, 2026, with the Board size increasing to nine directors. This is a clear executive appointment event. While the section also mentions that Mr. Pickard will receive compensation "in accordance with the Company's non-executive director compensation policy," the principal disclosed action is the appointment itself, not a compensatory arrangement modification. The appointment is material as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure presents the final voting results from Vital Farms' June 10, 2026 annual meeting of stockholders, covering three proposals: election of directors (Russell Diez-Canseco and Kelly Kennedy), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The tabulated vote counts for each proposal are the core content of the filing, matching the shareholder_vote_results event type precisely.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-16
Item 7.01
The Item 7.01 disclosure references entry into a "Purchase Agreement" and a "Transaction" announced via press release on June 16, 2026, with a Hong Kong Stock Exchange filing. While the specific nature of the transaction is not detailed in this excerpt, the language "entered into the Purchase Agreement" and formal Hong Kong regulatory filing suggest a material M&A or significant commercial transaction. However, without explicit confirmation of acquisition/disposition language or financial terms in this section alone, and given the vague reference to "the Transaction," the most defensible classification is other_material rather than ma_activity, though ma_activity remains plausible if the full press release (Exhibit 99.1) confirms acquisition or disposition activity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-16
EX-99.1
Optimi Health announced completion of production and commercial availability of two new standardized microdose psilocybin finished drug products (1mg and 2mg formulations). This represents a material operational and product-development milestone for a commercial-stage pharmaceutical manufacturer—the launch of new regulated drug products extends the company's product portfolio and supports its clinical research and patient-access business model. While not a discrete M&A, financing, or governance event, the announcement of new finished drug products available for clinical research and commercial supply is a material operational development that would affect a reasonable investor's assessment of the company's commercial progress and revenue potential.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-16
Item 7.01
The filing discloses entry into definitive agreements for the sale of Yum! Brands' Pizza Hut business, a material disposition. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 or 2.01, the substance is a material acquisition/disposition event that would significantly affect investor assessment of the company's portfolio and financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-16
Item 1.01
Open Lending Corporation entered into an Agreement and Plan of Merger with ANV Group Holdings Ltd. and Lakers Acquisition Sub, Inc. on June 15, 2026, whereby Merger Sub will commence a tender offer to purchase all outstanding shares at $3.15 per share, followed by a merger in which the Company becomes an indirect wholly owned subsidiary of Parent.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 8.01
Dominion Energy entered into an underwriting agreement on June 8, 2026 to issue $1.5 billion in aggregate principal amount of junior subordinated notes ($1 billion Series A due 2056 and $500 million Series B due 2056). While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories. This is a registered offering under an effective S-3 registration statement, not a dilutive unregistered equity issuance (which would be dilutive_issuance), and the disclosure focuses on the underwriting agreement and note terms rather than a broader M&A transaction or covenant event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-16
Item 8.01
Comstock sold a 27% minority equity interest in its midstream subsidiary Pinnacle Gas Services LLC to Sixth Street for $600 million. This constitutes a material disposition of a significant equity stake in a subsidiary, with proceeds used to retire $445 million in preferred equity and all outstanding indebtedness at Pinnacle. The transaction materially affects the capital structure and ownership of a key operating subsidiary.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-16
Item 3.02
The filing discloses an unregistered sale of 78,445 Class ER-A Common Shares for $2.3 million gross proceeds under a continuous private placement offering of up to $2.165 billion. The Company explicitly states reliance on Section 4(a)(2) and Regulation D Rule 506(c) exemptions from Securities Act registration requirements, which is the hallmark of a dilutive private equity issuance. This is material as it represents ongoing capital raising that dilutes existing shareholders and signals the Company's financing strategy.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-16
EX-99.1
The press release announces the successful pricing of €900,000,000 in aggregate principal amount of 4.500% Senior Notes due 2033 by Birkenstock Group B.V. & Co. KG, with settlement expected on June 19, 2026. This is a material creation of a new direct financial obligation. The proceeds will be used to redeem existing €428.5 million notes due 2029, finance share repurchases, and refinance other indebtedness—all material capital allocation decisions for the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Shareholders held on June 10, 2026, covering three proposals: election of a director (Seth J. Gersch), ratification of independent auditors, and advisory approval of named executive officer compensation. The filing explicitly states Item 5.07 and presents final voting tallies with votes for, against, abstain, and broker non-votes for each proposal, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-16
Per Narvinger has been appointed President and CEO of Ericsson effective October 1, 2026, by the Board of Directors. While the filing also discloses Börje Ekholm's departure as CEO on September 30, 2026, the principal announced action is the appointment of a new CEO to lead the company. This is a material executive appointment at the highest level of the organization.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-16
Item 8.01
CarMax Auto Funding LLC completed a material securitization transaction on June 16, 2026, involving the issuance of $600 million in asset-backed notes backed by motor vehicle retail installment sale contracts. The disclosure details the entry into multiple transaction agreements (Amended and Restated Trust Agreement, Grantor Trust Agreement, Receivables Purchase Agreement, Sale and Servicing Agreement, Indenture, and related ancillary agreements) that collectively constitute a material financing/capital markets activity. While technically a securitization rather than a traditional M&A transaction, this represents a significant material event affecting the registrant's capital structure and financial position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the results of Heron Therapeutics' 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on six proposals: director elections, auditor ratification, say-on-pay advisory vote, equity plan amendments, ESPP plan amendment, and Tax Benefits Preservation Plan ratification. The detailed vote tallies for each proposal are the core content of the filing, which is the standard form and substance of shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-16
Item 1.01
The filing discloses entry into a material definitive agreement for the sale of the domain name "www.mom.com" and related social media accounts to Static Media, Inc. for $1.1 million. This constitutes a material disposition under Item 1.01, with the proceeds being used to prepay debt obligations under the company's credit agreement. The transaction required lender consent and triggered amendments to the Credit Agreement, indicating materiality to the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-16
Item 5.07
Nexstar Media Group held its Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on four proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, and approval of the 2026 Long-Term Omnibus Incentive Plan. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Q32 Bio's 2026 Annual Meeting of Stockholders. The filing presents voting results for three proposals: election of Class II directors (Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D.), ratification of Ernst & Young LLP as independent auditor, and advisory vote on named executive officer compensation. The detailed vote tallies and quorum information (75.71% of shares represented) are characteristic of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-16
Item 8.01
CNB Financial Corporation completed a partial redemption of $50 million in subordinated debt (3.25% Fixed-to-Floating Rate Subordinated Notes due 2031) at par plus accrued interest. While this is a material capital management action affecting the corporation's debt structure and financial position, it does not fit neatly into the more specific event categories (not a covenant breach, not a restatement, not an impairment). The redemption is disclosed as a completed transaction under Item 8.01 (Other Events), indicating it is material to investors but lacks a dedicated 8-K item classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Graphic Packaging held its Annual Meeting of Stockholders on June 11, 2026, with shareholders voting on six proposals: election of three directors, ratification of PricewaterhouseCoopers LLP as auditor, Say-on-Pay compensation approval, board declassification amendment, special meeting call amendment, and a stockholder proposal. The filing discloses detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-16
EX-99.1
The exhibit announces the appointment of Dirk Van de Put as AB InBev's new Chairman, effective 16 June 2026, succeeding Martin J. Barrington who retired. This is a material governance event involving the appointment of a director to a senior leadership position (Chairman). The disclosure explicitly states the Board "unanimously selected" Van de Put and provides his background and qualifications, which is characteristic of an executive appointment disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-16
Item 5.02
The filing discloses the appointment of Jennifer Biry as Deputy Chief Financial Officer effective July 6, 2026, with her assuming the role of Senior Executive Vice President and Chief Financial Officer as of January 1, 2027. While Pascal Desroches's retirement is also mentioned, the principal disclosed action centers on Biry's appointment to a critical C-suite role. This is material as CFO succession at a major corporation affects investor assessment of financial leadership and governance.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 72%
filed 2026-06-16
Item 1.01
FiscalNote entered into a waiver agreement with noteholder GPO to defer a $2.0 million quarterly principal amortization payment due July 1, 2026, and is actively engaging with senior and subordinated lenders to renegotiate or amend existing obligations. The deferral and broad restructuring discussions signal financial stress and inability to meet scheduled debt obligations, indicating material covenant-related distress.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Cytek Biosciences' June 10, 2026 annual meeting. The filing reports voting outcomes on three matters: election of Class II directors (Vera Imper, Glenn P. Muir, and Ming Yan), advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three matters passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely on to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-16
Item 1.01
Allison Transmission Holdings Inc. entered into Amendment No. 6 to its Credit Agreement, refinancing approximately $508 million of term loan debt and reducing the applicable margin by 0.25%. This material debt restructuring affects the registrant's capital structure and cost of debt.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder vote results from Global Self Storage's 2026 Annual Stockholders Meeting under Item 5.07. The filing presents voting outcomes for four proposals: election of five directors, approval of an amended 2017 Equity Incentive Plan, ratification of RSM US LLP as independent auditor, and an advisory vote on executive compensation. All proposals passed with requisite votes. This is material as it documents formal stockholder actions on governance and compensation matters.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-16
The 6-K discloses the successful pricing of a €900 million offering of 4.500% Senior Notes due 2033 by Birkenstock Group B.V. & Co. KG on June 16, 2026. This is a material debt issuance creating a direct financial obligation. The filing also updates risk factors and other disclosure in connection with this offering, including discussion of leverage, debt service obligations, and restrictive covenants. The body of the report is primarily supplemental disclosure to the Annual Report on Form 20-F, with the debt offering as the triggering event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
HubSpot held its Annual Meeting of Stockholders on June 15, 2026, with shareholders voting on six proposals including director elections, auditor ratification, executive compensation approval, Amendment No. 1 to the 2024 Stock Option and Incentive Plan (increasing share reserve by 2,300,000 shares), a stockholder proposal on special meeting rights, and an adjournment proposal. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from RxSight's 2026 Annual Meeting held on June 16, 2026, covering three matters: election of three Class II directors (William J. Link, Robert Warner, and Shweta Singh Maniar), advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
The filing discloses a regular quarterly cash distribution of $0.14 per BUC declared by the Board of Managers on June 16, 2026, payable July 31, 2026. While this is a routine distribution announcement for a BDC-like entity, it does not fit cleanly into the standard 8-K taxonomy (not earnings_release, which typically involves full financial results; not exec_compensation, which concerns officer/director pay). The distribution is material to investors as it affects the total return and cash flow expectations for BUC holders, warranting disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from Zeta Global's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents final vote tallies for three proposals: election of Class II directors (William Landman, Robert Niehaus, and Jeanine Silberblatt), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The Item 5.07 classification and detailed voting counts (For/Against/Withheld/Abstain/Broker Non-Votes) are unmistakable indicators of shareholder vote results disclosure, which is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from Five Below's 2026 Annual Meeting held on June 16, 2026, filed under Item 5.07. The filing presents final voting tallies for four proposals: election of nine directors, ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and a shareholder proposal on majority voting standards. All results are material to investors' understanding of governance and board composition.
View raw filing on EDGAR →